ExploreWatchlistsPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Cash from financing

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (E25678)

Market cap
P/E ratio
Taisho Pharmaceutical Holdings develops and sells both over-the-counter and prescription medicines, along with health products, serving customers in Japan and internationally.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2023-10,877+8.15%
Mar 31, 2022-10,057-11.36%
Mar 31, 2021-11,346-2.99%
Mar 31, 2020-11,696-24.38%
Mar 31, 2019-15,467+56.75%
Mar 31, 2018-9,867+17.41%
Mar 31, 2017-8,404-56.96%
Mar 31, 2016-19,525+106.77%
Mar 31, 2015-9,443+0.04%
Mar 31, 2014-9,439-6.21%
Mar 31, 2013-10,064

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat